Institutional shares held 35.1 Million
256K calls
187K puts
Total value of holdings $496M
$3.61M calls
$2.64M puts
Market Cap $4.95B
350,000,000 Shares Out.
Institutional ownership 10.02%
# of Institutions 127


Latest Institutional Activity in BLCO

Top Purchases

Q4 2024
Alberta Investment Management Corp Shares Held: 3.01M ($42.5M)
Q4 2024
Price T Rowe Associates Inc Shares Held: 782K ($11M)
Q4 2024
Citadel Advisors LLC Shares Held: 884K ($12.5M)
Q4 2024
Arrowstreet Capital, Limited Partnership Shares Held: 1.22M ($17.2M)
Q4 2024
King Street Capital Management, L.P. Shares Held: 1.14M ($16.1M)

Top Sells

Q1 2025
Rhumbline Advisers Shares Held: 107 ($1.51K)
Q4 2024
Goldentree Asset Management LP Shares Held: 1.73M ($24.5M)
Q4 2024
Exodus Point Capital Management, LP Shares Held: 367K ($5.18M)
Q4 2024
River Road Asset Management, LLC Shares Held: 1.51M ($21.3M)
Q4 2024
Maple Rock Capital Partners Inc. Shares Held: 3.17M ($44.8M)

About BLCO

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.


Insider Transactions at BLCO

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
561K Shares
From 17 Insiders
Grant, award, or other acquisition 529K shares
Open market or private purchase 32.3K shares
Sell / Disposition
160K Shares
From 7 Insiders
Payment of exercise price or tax liability 160K shares

Track Institutional and Insider Activities on BLCO

Follow Bausch & Lomb Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLCO shares.

Notify only if
Any

Insider Trading

Get notified when an Bausch & Lomb Corp insider buys or sells BLCO shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Bausch & Lomb Corp

Track Activities on BLCO